Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s13075-015-0846-4 http://scihub22266oqcxt.onion/10.1186/s13075-015-0846-4 C4635990!4635990!26542940     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Arthritis+Res+Ther 2015 ; 17 (ä): ä Nephropedia Template TP {{tp|p=26542940|t=2015. Semaphorin 4A as novel regulator and promising therapeutic target in rheumatoid arthritis |pdf=|usr=}}{{26542940}} gab.com Text Semaphorin 4A as novel regulator and promising therapeutic target in rheumatoid arthritis JO: Arthritis Res Ther http://www.kidney.de/pget.php?&tw=1&pmid=26542940 #FOAvip Rheumatoid arthritis (RA) is a systemic autoimmune disease manifesting in joint destruction. The recognized hallmark of RA pathogenesis is the involvement of immune cells which produce many mediators potentiating an inflammatory environment. RA synovial fibroblasts (RASFs) contribute significantly to disease progression by initiating and regulating many pathways of joint destruction. Detailed molecular insights into RASF biology may lead to identification of important therapeutic targets. The discovery of common molecular targets for joint resident and inflammatory cells may help to develop the most effective therapeutic strategy. One such pathway includes semaphorin 4A as reported in a recent article in Arthritis Research & Therapy. Twit Text FOAVip Semaphorin 4A as novel regulator and promising therapeutic target in rheumatoid arthritis ????Arthritis Res Ther http://www.kidney.de/pget.php?&tw=1&pmid=26542940 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26542940 #FOAvip English Wikipedia <ref>{{Cite pmid|26542940}}</ref> Semaphorin 4A as novel regulator and promising therapeutic target in rheumatoid arthritis #MMPMID26542940 Chapoval SP Arthritis Res Ther 2015[]; 17 (ä): ä PMID26542940show ga Rheumatoid arthritis (RA) is a systemic autoimmune disease manifesting in joint destruction. The recognized hallmark of RA pathogenesis is the involvement of immune cells which produce many mediators potentiating an inflammatory environment. RA synovial fibroblasts (RASFs) contribute significantly to disease progression by initiating and regulating many pathways of joint destruction. Detailed molecular insights into RASF biology may lead to identification of important therapeutic targets. The discovery of common molecular targets for joint resident and inflammatory cells may help to develop the most effective therapeutic strategy. One such pathway includes semaphorin 4A as reported in a recent article in Arthritis Research & Therapy. äSemaphorin 4A as novel regulator and promising therapeutic target in r(epmc).pdf DeepDyve Pubget Overpricing